MauraLGillisonMD

Oncology • Houston, TX

Professor, Internal Medicine, Ohio State University College of Medicine

Join to view full profile

Dr. Gillison is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gillison's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6127

Fax+1 713-745-7296
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
Johns Hopkins UniversityInternship, Internal Medicine, 1992 - 1993
Johns Hopkins University School of MedicineClass of 1991

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 2016 - 2026
MD State Medical License 1996 - 2024
OK State Medical License 2020 - 2021
OH State Medical License 2009 - 2019
IL State Medical License 2016 - 2017

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 2010

Clinical Trials

Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer Start of enrollment: 2002 Oct 01
Completed
Phase 1
A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC Start of enrollment: 2009 Jul 01
Terminated
Phase 1
Oral HPV Infection in Young Men Start of enrollment: 2007 May 01
Completed
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2009 Nov 01
Active, not recruiting
Phase 3
Everolimus Versus Placebo in Head and Neck Cancer Start of enrollment: 2010 Apr 01
Terminated
Phase 2
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer Start of enrollment: 2011 Jun 01
Active, not recruiting
Phase 3
TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15
Completed
Phase 2
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2014 Apr 14
Completed
Phase 1
Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) Start of enrollment: 2014 May 29
Completed
Phase 3
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer Start of enrollment: 2014 Jan 01
Completed
Phase 1
Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma Start of enrollment: 2019 Jul 25
Recruiting
Phase 2
Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin Start of enrollment: 2021 Dec 20
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
Tanguy Y Seiwert, Sophie Wildsmith, Jérôme Fayette, Kevin Harrington, Maura Gillison, Myung-Ju Ahn, Shunji Takahashi, Jared Weiss, Jean-Pascal Machiels, Shrujal Baxi, ...> ;Cancer Immunology, Immunotherapy. 2024 Mar 2
1 citations
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
Laila A Gharzai, Emily Morris, Krithika Suresh, Phuc Felix Nguyen-Tân, David I Rosenthal, Maura L Gillison, Paul M Harari, Adam S Garden, Shlomo Koyfman, Jimmy J Caude...> ;The Lancet. Oncology. 2024 Mar 1
1 citations
Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years.
Gypsyamber D'Souza, Sakshi R Tewari, Tanya Troy, Jennifer Webster-Cyriaque, Dorothy J Wiley, Cecile Delille Lahiri, Maura L Gillison, Howard D Strickler, Linda Struijk...> ;Cancer Epidemiology, Biomarkers & Prevention. 2024 Apr 3
Expanding Research in Cancer Epidemiology in.
Cheng, I., Wheeler, S., Iasonos, A., Gillison, M., Bhatia, S.> ;Journal of Clinical Oncology. 2024 Mar 1
Flashback Foreword: Chemoradiotherapy for Nasopharyngeal Carcinoma.
Maura L Gillison> ;Journal of Clinical Oncology. 2023 Aug 20
Flashback Foreword: Human Papillomavirus and Incidence and Survival of Oropharyngeal Cancers.
Maura L Gillison> ;Journal of Clinical Oncology. 2023 Jun 10
36 citations
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.
Yanshuo Chu, Enyu Dai, Yating Li, Guangchun Han, Guangsheng Pei, Davis R Ingram, Krupa Thakkar, Jiang-Jiang Qin, Minghao Dang, Xiuning Le, Can Hu, Qing Deng, Ansam Sin...> ;Nature Medicine. 2023 Jun 1
16 citations
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 ...
Kevin J Harrington, Robert L Ferris, Maura Gillison, Makoto Tahara, Athanasios Argiris, Jérôme Fayette, Michael Schenker, Åse Bratland, John W T Walker, Peter Grell, C...> ;JAMA Oncology. 2023 Jun 1
1 citations
Noninvasive genomic profiling of somatic mutations in oral cavity cancers.
Yuanxin Xi, Marcelo V Negrao, Keiko Akagi, Weihong Xiao, Bo Jiang, Sarah C Warner, Joe Dan Dunn, Jing Wang, David E Symer, Maura L Gillison> ;Oral Oncology. 2023 May 1
1 citations
F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results...
Rathan M Subramaniam, Lyudmila DeMora, Min Yao, Sue S Yom, Maura Gillison, Jimmy J Caudell, John Waldron, Ping Xia, Christine H Chung, Minh Tam Truong, Michelle Echeva...> ;Journal of Nuclear Medicine. 2023 Mar 1
13 citations
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration.
Keiko Akagi, David E Symer, Medhat Mahmoud, Bo Jiang, Sara Goodwin, Darawalee Wangsa, Zhengke Li, Weihong Xiao, Joe Dan Dunn, Thomas Ried, Kevin R Coombes, Fritz J Sed...> ;Cancer Discovery. 2023 Apr 3
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study.
Rebecca Landy, Gregory Haber, Barry I Graubard, Nicole G Campos, Stephen Sy, Jane J Kim, Emily A Burger, Li C Cheung, Hormuzd A Katki, Maura L Gillison, Anil K Chaturvedi> ;Journal of the National Cancer Institute. 2023 Apr 11
4 citations
Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma.
Niamh Coleman, Kathrina L Marcelo, Julia F Hopkins, Nusrat Israr Khan, Robyn Du, Lingzhi Hong, Edward Park, Binaifer Balsara, Mollie Leoni, Curtis Pickering, Jeffrey M...> ;JCO Precision Oncology. 2023 Jan 1
29 citations
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KE...
A Psyrri, J Fayette, K Harrington, M Gillison, M-J Ahn, S Takahashi, J Weiss, J-P Machiels, S Baxi, A Vasilyev, A Karpenko, M Dvorkin, C-Y Hsieh, S C Thungappa, P P Se...> ;Annals of Oncology. 2023 Mar 1
24 citations
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of Ch...
Robert I Haddad, Kevin Harrington, Makoto Tahara, Robert L Ferris, Maura Gillison, Jerome Fayette, Amaury Daste, Piotr Koralewski, Bogdan Zurawski, Miren Taberna, Nabi...> ;Journal of Clinical Oncology. 2023 Apr 20
2 citations
Representative oral microbiome data for the US population: the National Health and Nutrition Examination Survey.
Emily Vogtmann, Anil K Chaturvedi, Martin J Blaser, Nicholas A Bokulich, J Gregory Caporaso, Maura L Gillison, Xing Hua, Autumn G Hullings, Rob Knight, Vaishnavi Puran...> ;The Lancet. Microbe. 2023 Feb 1
4 citations
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
Cherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, Olivier Harismendy, José M Flores, Tara Moore-Medlin, Everett E Vokes, J Silvio Gutkind, Prakash Neupane, Glenn M...> ;Clinical Cancer Research. 2022 Dec 1
3 citations
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Founda...
Maura L Gillison, Robert L Ferris, Jonathan Harris, A Dimitrios Colevas, Loren K Mell, Christina Kong, Richard C Jordan, Kevin L Moore, Minh-Tam Truong, Claudia Kirsch...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Mar 15
7 citations
Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An Int...
Feixue Wei, Marc T Goodman, Ningshao Xia, Jun Zhang, Anna R Giuliano, Gypsyamber D'Souza, Nancy A Hessol, Maarten F Schim van der Loeff, Jianghong Dai, Karin Neukam, A...> ;Clinical Infectious Diseases. 2023 Feb 8
4 citations
Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection.
Xiuning Le, Frederico O Gleber-Netto, M Laura Rubin, Yun Qing, Robyn Du, Merrill Kies, George Blumenschein Jr, Charles Lu, Faye M Johnson, Diana Bell, Jeff Lewis, Jiex...> ;Clinical Cancer Research. 2022 Apr 20
32 citations
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.
Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, Benjamin H Hinrichs, Francis P Worden, Matthew O Old, Neal E Dunlap, John M Kaczmar, Yash Patil, Muhammed Kash...> ;Clinical Cancer Research. 2022 Apr 1
9 citations
Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium.
Neerav Goyal, Max Hennessy, Erik Lehman, Wenxue Lin, Antonio Agudo, Wolfgang Ahrens, Stefania Boccia, Paul Brennan, Hermann Brenner, Gabriella Cadoni, Cristina Canova,...> ;Oral Diseases. 2023 May 1
17 citations
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
Maura L Gillison, George Blumenschein, Jerome Fayette, Joel Guigay, A Dimitrios Colevas, Lisa Licitra, Kevin J Harrington, Stefan Kasper, Everett E Vokes, Caroline Eve...> ;The Oncologist. 2022 Mar 4
229 citations
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
Jimmy J Caudell, Maura L Gillison, Ellie Maghami, Sharon Spencer, David G Pfister, Douglas Adkins, Andrew C Birkeland, David M Brizel, Paul M Busse, Anthony J Cmelak, ...> ;Journal of the National Comprehensive Cancer Network. 2022 Mar 1
16 citations
Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers.
David E Symer, Keiko Akagi, Heather M Geiger, Yang Song, Gaiyun Li, Anne-Katrin Emde, Weihong Xiao, Bo Jiang, André Corvelo, Nora C Toussaint, Jingfeng Li, Amit Agrawa...> ;Genome Research. 2022 Jan 1
Join now to see all

Lectures

Safety and disease control achieved with the addition of nivolumab (Nivo) to chemoradiotherapy (CRT) for intermediate (IR) and high-risk (HR) local-regionally advanced...
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

MD Anderson Research Highlights for February 22, 2023February 22nd, 2023
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab plus Atezolizumab in Patients with Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC)January 11th, 2023
Cancer on the Rise, and HPV Vaccine Too Late for Gen XDecember 15th, 2022
Join now to see all

Grant Support

A Therapeutic Vaccine For HPV 16-Positive Head And Neck CancerNational Cancer Institute2007–2008
Oral HPV Infection In Hiv-Infected Men And WomenNational Institute Of Dental &Craniofacial Research2005–2008
Human Oral Papillomavirus Etiology (HOPE) StudyNational Center For Research Resources2007
HOPE Pilot 2National Center For Research Resources2006–2007
Head And Neck Squamous Cell CarcinomaNational Center For Research Resources2006–2007
OSI-774 In Patients With Oral Cavity Or Oropharyngeal CancerNational Center For Research Resources2004–2007
HPV Vaccine Therapy /Correlates In Head/Neck CarcinomaNational Cancer Institute2002